BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2424262)

  • 21. C1 activation, with C1q in excess of functional C1 in synovial fluid from patients with rheumatoid arthritis.
    Sjöholm AG; Berglund K; Johnson U; Laurell AB; Sturfelt G
    Int Arch Allergy Appl Immunol; 1986; 79(2):113-9. PubMed ID: 3484727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Component deficiencies. 1. The first component: C1q, C1r, C1s.
    Loos M; Heinz HP
    Prog Allergy; 1986; 39():212-31. PubMed ID: 3031693
    [No Abstract]   [Full Text] [Related]  

  • 23. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
    Thielens NM; Illy C; Bally IM; Arlaud GJ
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C1q binding and complement activation by capsular and cell wall components of S. pneumoniae type XIX.
    Prellner K
    Acta Pathol Microbiol Scand C; 1981 Dec; 89(6):359-64. PubMed ID: 6278825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective analysis of C1 dissociation and complement activation in patients with systemic lupus erythematosus.
    Jonsson H; Sturfelt G; Mårtensson U; Truedsson L; Sjöholm AG
    Clin Exp Rheumatol; 1995; 13(5):573-80. PubMed ID: 8575134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement components, complement activation, and acute phase response in systemic lupus erythematosus.
    Sturfelt G; Sjöholm AG
    Int Arch Allergy Appl Immunol; 1984; 75(1):75-83. PubMed ID: 6086533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired IgG2 anti-pneumococcal antibody responses in patients with recurrent infection and normal IgG2 levels but no IgA.
    Lane PJ; MacLennan IC
    Clin Exp Immunol; 1986 Aug; 65(2):427-33. PubMed ID: 3791703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severity of infections in IgA deficiency: correlation with decreased serum antibodies to pneumococcal polysaccharides and decreased serum IgG2 and/or IgG4.
    French MA; Denis KA; Dawkins R; Peter JB
    Clin Exp Immunol; 1995 Apr; 100(1):47-53. PubMed ID: 7697922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hereditary complement deficiencies].
    Fischer E
    Hautarzt; 1982 Feb; 33(2):65-72. PubMed ID: 6281215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination.
    Koskela M
    Pediatr Infect Dis J; 1987 Jun; 6(6):519-26. PubMed ID: 3615065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and analysis of immune complexes from sera of patients with polymyalgia rheumatica and giant cell arteritis.
    Smith AJ; Kyle V; Cawston TE; Hazleman BL
    Ann Rheum Dis; 1987 Jun; 46(6):468-74. PubMed ID: 2820320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural and functional studies in C1q deficiency.
    Chapuis RM; Hauptmann G; Grosshans E; Isliker H
    J Immunol; 1982 Oct; 129(4):1509-12. PubMed ID: 6980939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
    Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
    Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type-specific anti-pneumococcal antibodies in a vaccinated patient with combined immunoglobulin A and IgG2 deficiency and invasive pneumococcal infections.
    Bruyn GA; Hiemstra PS; Rijkers GT
    J Infect Dis; 1992 Dec; 166(6):1460-1. PubMed ID: 1431269
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of serum antibodies to pneumolysin with those to pneumococcal capsular polysaccharides in children with acute otitis media.
    Virolainen A; Jero J; Chattopadhyay P; Karma P; Eskola J; Leinonen M
    Pediatr Infect Dis J; 1996 Feb; 15(2):128-33. PubMed ID: 8822285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C1 activation and dissociation in disease.
    Laurell AB; Mårtensson U; Sjöholm AG
    Immunol Lett; 1987 Feb; 14(3):249-53. PubMed ID: 3032782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement analysis in adult patients with a history of bacteremic pneumococcal infections or recurrent pneumonia.
    Ekdahl K; Truedsson L; Sjöholm AG; Braconier JH
    Scand J Infect Dis; 1995; 27(2):111-7. PubMed ID: 7660072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C1 dissociation in serum: estimation of free C1q by electroimmunoassay.
    Sjöholm AG; Mårtensson U; Laurell AB
    Acta Pathol Microbiol Immunol Scand C; 1985 Aug; 93(4):161-8. PubMed ID: 3876685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biosynthesis of the subcomponents C1q, C1r and C1s of the first component of complement (C1) by guinea pig hepatocyte primary cultures.
    Ramadori G; Heinz HP; Martin H; Meyer zum Büschenfelde KH; Loos M
    Eur J Immunol; 1986 Sep; 16(9):1137-41. PubMed ID: 3019707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surfactant protein A regulates complement activation.
    Watford WT; Wright JR; Hester CG; Jiang H; Frank MM
    J Immunol; 2001 Dec; 167(11):6593-600. PubMed ID: 11714829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.